Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date07 May 2018 |
100 Clinical Results associated with Shenwei Pharmaceutical(Sichuan)Co.,Ltd.
0 Patents (Medical) associated with Shenwei Pharmaceutical(Sichuan)Co.,Ltd.
100 Deals associated with Shenwei Pharmaceutical(Sichuan)Co.,Ltd.
100 Translational Medicine associated with Shenwei Pharmaceutical(Sichuan)Co.,Ltd.